Clinical Trial Update: Carbohydrate Antigen 125-guided Therapy in Heart Failure [Phase 4]

View source ↗

Summary

A Phase 4 trial investigating carbohydrate antigen 125-guided therapy for heart failure has completed; the update does not provide detailed results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia | Conditions: Heart Failure | Phase 4 | Status: COMPLETED